Fresenius Medical Care AG & Co. KGaA $FMS Stock: Teachers Retirement System of The State of Kentucky Raises Holdings

Teachers Retirement System of The State of Kentucky boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Free Report) by 35.6% during the third quarter, Holdings Channel reports. The fund owned 1,106,400 shares of the company’s stock after acquiring an additional 290,200 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $24,761,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC increased its position in Fresenius Medical Care AG & Co. KGaA by 39.1% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,915 shares of the company’s stock valued at $43,000 after acquiring an additional 538 shares in the last quarter. Allworth Financial LP lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 31.5% during the second quarter. Allworth Financial LP now owns 3,552 shares of the company’s stock worth $80,000 after purchasing an additional 850 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 27.9% during the first quarter. Parallel Advisors LLC now owns 4,632 shares of the company’s stock valued at $104,000 after purchasing an additional 1,011 shares during the last quarter. Trek Financial LLC grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 9.2% during the third quarter. Trek Financial LLC now owns 12,350 shares of the company’s stock valued at $276,000 after purchasing an additional 1,040 shares during the last quarter. Finally, Mather Group LLC. grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 838.0% during the third quarter. Mather Group LLC. now owns 1,407 shares of the company’s stock valued at $31,000 after purchasing an additional 1,257 shares during the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Zacks Research downgraded Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Sanford C. Bernstein lifted their price target on shares of Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the stock a “market perform” rating in a research report on Thursday, August 6th. Weiss Ratings upgraded Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. BNP Paribas Exane lowered Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 target price on the stock. in a research report on Tuesday, July 28th. Finally, Berenberg Bank set a $24.00 price objective on Fresenius Medical Care AG & Co. KGaA in a report on Tuesday, September 29th. Seven analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $23.42.

Get Our Latest Analysis on FMS

Fresenius Medical Care AG & Co. KGaA Stock Down 0.8%

Shares of FMS opened at $21.85 on Tuesday. Fresenius Medical Care AG & Co. KGaA has a 52 week low of $20.02 and a 52 week high of $26.42. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 12.63, a PEG ratio of 4.99 and a beta of 0.78. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.69 and a current ratio of 0.99. The stock has a fifty day moving average of $22.28 and a 200-day moving average of $22.90.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.64 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.01). The company had revenue of $5.59 billion for the quarter, compared to analyst estimates of $5.52 billion. Fresenius Medical Care AG & Co. KGaA had a return on equity of 9.08% and a net margin of 4.23%. As a group, sell-side analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.23 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Company Profile

(Free Report)

Fresenius Medical Care AG & Co. KGaA is a healthcare company focused on treating people with chronic kidney failure. It provides dialysis care through a global network of treatment centers and supports patients who receive care in clinics or at home. The company also develops and supplies products used in dialysis, including dialysis machines, dialyzers, and related medical equipment and materials. Its services include clinical care and support for healthcare providers involved in kidney treatment.

See Also

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Free Report).

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.